Table 3 Uni- and multivariable analysis to predict pCR in the tumors based on the pretreatment ADC values

Tumors

Odds ratio

95% CI

p-value

Overall sample

4.65

1.40–15.49

0.012

HER2-enriched tumors

29.12

1.95–434.22

0.014

Triple negative tumors

15.78

1.71–145.53

0.015

Luminal B tumors

35.81

1.19–1075.04

0.039

Tumors

Odds ratio

95% CI

p-value

Overall sample

3.00

0.85–10.63

0.088

HER2-enriched tumors

76.98

2.75–2154.73

0.011

Triple negative tumors

19.20

0.96–382.16

0.053

Luminal B tumors

54.86

1.26–2390.30

0.038